Back to Search
Start Over
[Effectiveness of trans-retinoic acid in the treatment of acute promyelocytic leukemia: initial results of a multicenter study].
- Source :
-
Terapevticheskii arkhiv [Ter Arkh] 1999; Vol. 71 (7), pp. 20-4. - Publication Year :
- 1999
-
Abstract
- Aim: Evaluation of trans-retinoic acid (ATRA) in combination with cytostatic drugs in treatment of acute promyelocytic leukemia (APL).<br />Materials and Methods: In a multicenter study APL was treated according to protocols APL 01.97 and APL 06.87 in 28 patients (14 males and 14 females, median age 36 years).<br />Results: Administration of ATRA in combination with standard program 7 + 3 (cytosine-arabinoside 100 mg/m2 twice a day v.v. day 1-7, daunorubicin 60 mg/m2 v.v. day 1-3) induced a complete remission in 25 patients (90%). Early lethality was 10% (3 patients died). Resistant APL was not registered. Retinoid syndrome was diagnosed in 15 patients, one patient died. 2-year overall and recurrence-free survival made up 72 and 82%, respectively.<br />Conclusion: ATRA combination with cytosine-arabinoside and daunorubicin is a novel treatment of acute promyelocytic leukemia providing a high rate of complete remission and long-term survival.
- Subjects :
- Adolescent
Adult
Antimetabolites, Antineoplastic administration & dosage
Antineoplastic Agents administration & dosage
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Cytarabine administration & dosage
Daunorubicin administration & dosage
Female
Humans
Leukemia, Promyelocytic, Acute mortality
Male
Middle Aged
Remission Induction
Time Factors
Treatment Outcome
Tretinoin administration & dosage
Antineoplastic Agents therapeutic use
Leukemia, Promyelocytic, Acute drug therapy
Tretinoin therapeutic use
Subjects
Details
- Language :
- Russian
- ISSN :
- 0040-3660
- Volume :
- 71
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Terapevticheskii arkhiv
- Publication Type :
- Academic Journal
- Accession number :
- 10481862